Joan Tymon‐Rosario

Integrated mutational landscape analysis of uterine leiomyosarcomas

Jungmin Choi, Aránzazu Manzano, Weilai Dong et al. · Proceedings of the National Academy of Sciences · 2021 · 113 citations · Full text

Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort study

Britt Erickson, Omar Najjar, Shari Damast et al. · Gynecologic Oncology · 2020 · 83 citations · Full text

Multi-institutional Cohort Study, Tumoral Pathology, Medicine +7

A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability

Stefania Bellone, Dana M. Roque, Eric R. Siegel et al. · Cancer · 2021 · 72 citations · Full text

Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan

Burak Zeybek, Aránzazu Manzano, Anna Bianchi et al. · Scientific Reports · 2020 · 58 citations · Full text

Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer

Emanuele Perrone, Salvatore Lopez, Burak Zeybek et al. · Frontiers in Oncology · 2020 · 57 citations · Full text